Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: A single-institution experience

Circulation

Volumn 123, Issue 17, 2011, Pages 1836-1842

  Suda, Kenji ^a,b   Iemura, Motofumi ^a,b   Nishiono, Hiroshi ^a   Teramachi, Yozo ^a   Koteda, Yusuke ^a   Kishimoto, Shintaro ^a   Kudo, Yoshiyuki ^a   Itoh, Shinichi ^a   Ishii, Haruka ^a   Ueno, Takafumi ^a   Tashiro, Tadashi ^c   Nobuyoshi, Masakiyo ^d   Kato, Hirohisa ^a,b   Matsuishi, Toyojiro ^a,b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Cardiovascular Research Institute   (Japan)

^c FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KOKURA MEMORIAL HOSPITAL   (Japan)

Author keywords

aneurysm; coronary artery disease; mucocutaneous lymph node syndrome; outcome assessment

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; STEROID; WARFARIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CORONARY ARTERY ANEURYSM; FEMALE; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HUMAN; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; ONSET AGE; PERCUTANEOUS CORONARY INTERVENTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RIGHT CORONARY ARTERY; SCHOOL CHILD; SURVIVAL RATE;

EID: 85027958680     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.978213     Document Type: Article

References (38)

1. Yanagawa H, Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K. Incidence of Kawasaki disease in Japan: the nationwide surveys of 1999-2002. Pediatr Int. 2006;48:356-361. (Pubitemid 44127884)
2. Newburger JW, Fulton DR. Kawasaki disease. Curr Opin Pediatr. 2004; 16:508-514. (Pubitemid 39274385)
3. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T, Baba K, Mori C. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984;2:1055-1058. (Pubitemid 15211522)
4. Kato H, Koike S, Yamamoto M, Ito Y, Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr. 1975;86:892-898.
5. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, Durack DT; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116: 1736-1754.
6. Fukuzawa R, Igeam E, Watanabe M, Hajikano M, Kamisago M, Katsube Y, Yamauchi H, Ochi M, Ogawa S. Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence. Circ J. 2007;71:709-715. (Pubitemid 46683362)
7. Sugimura T, Kato H, Inoue O, Fukuda T, Sato N, Ishii M, Takagi J, Akagi T, Maeno Y, Kawano T. Intravascular ultrasound of coronary arteries in children: assessment of the wall morphology and the lumen after Kawasaki disease. Circulation. 1994;89:258-265. (Pubitemid 24026498)
8. Mitani Y, Ohashi H, Sawada H, Ikeyama Y, Hayakawa H, Takabayashi S, Maruyama K, Shimpo H, Komada Y. In vivo plaque composition and morphology in coronary artery lesions in adolescents and young adults long after Kawasaki disease: a virtual histology-intravascular ultrasound study. Circulation. 2009;119:2829-2836.
9. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R. Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379-1385. (Pubitemid 26307269)
10. Onouchi Z, Hamaoka K, Sakata K, Ozawa S, Shiraishi I, Itoi T, Kiyosawa N. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens. Circ J. 2005;69:265-272. (Pubitemid 40410179)
11. Harada K, Kato H, Akagi T, Karasawa K, Kitamura S, Saji T, Suzuki A, Baba K, Fujiwara H. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS2003), Circ J. 2003;67: 1111-1138.
12. Kato H, Inoue O, Ichinose E, Akagi T. Intracoronary thrombolytic therapy in Kawasaki disease: treatment and prevention of myocardial infarction. Prog Clin Biol Res. 1987;250:445-454.
13. Sugimura T, Yokoi H, Sato N, Akagi T, Kimura T, Iemura M, Nobuyoshi M, Kato H. Interventional treatment for children with severe coronary artery stenosis with calcification after long-term Kawasaki disease. Circulation. 1997;96:3928-3933.
14. Ueno T, Kai H, Ikeda H, Ichiki K, Hashino T, Imaizumi T. Coronary stent deployment in a young adult with Kawasaki disease and recurrent myocardial infarction. Clin Cardiol. 1999;22:147-149. (Pubitemid 29077408)
15. Ishii M, Ueno T, Ikeda H, Iemura M, Sugimura T, Furui J, Sugahara Y, Muta H, Akagi T, Nomura Y, Homma T, Yokoi H, Nobuyoshi M, Matsuishi T, Kato H. Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation. 2002; 105:3004-3010. (Pubitemid 34693834)
16. Levy DM, Silverman ED, Massicotte MP, McCrindle BW, Yeung RS. Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease. J Rheumatol. 2005;32:928-934. (Pubitemid 40676506)
17. Akagi T, Ogawa S, Ino T, Iwasa M, Echigo S, Kishida K, Baba K, Matsushima M, Hamaoka K, Tomita H, Ishii M, Kato H. Catheter interventional treatment in Kawasaki disease: a report from the Japanese Pediatric Interventional Cardiology Investigation group. J Pediatr. 2000; 137:181-186. (Pubitemid 30659224)
18. Ishii M, Ueno T, Akagi T, Baba K, Harada K, Hamaoka K, Kato H, Tsuda E, Uemura S, Saji T, Ogawa S, Echigo S, Yamaguchi T, Kato H; Research Committee of Ministry of Health, Labour and Welfare. Study of treatment and long-term management in Kawasaki disease: guidelines for catheter intervention in coronary artery lesion in Kawasaki disease. Pediatr Int. 2001;43:558-562. (Pubitemid 34205863)
19. Takeuchi Y, Suma K, Shiroma K, Asai T, Kusakawa S. Surgical experience with coronary arterial sequelae of Kawasaki disease in children. J Cardiovasc Surg (Torino). 1981;22:231-238. (Pubitemid 11055704)
20. Kitamura S, Tsuda E, Kobayashi J, Nakajima H, Yoshikawa Y, Yagihara T, Kada A. Twenty-five-year outcome of pediatric coronary artery bypass surgery for Kawasaki disease. Circulation. 2009;120:60-68.
21. Ino T, Nishimoto K, Akimoto K, Park I, Shimazaki S, Yabuta K, Yamaguchi H. Percutaneous transluminal coronary angioplasty for Kawasaki disease: a case report and literature review. Pediatr Cardiol. 1991;12:33-35.
22. Nishimura H, Sawada T, Azuma A, Kohno Y, Katsume H, Nakagawa M, Sakata K, Hamaoka K, Onouchi Z. Percutaneous transluminal coronary angioplasty in a patient with Kawasaki disease: a case report of an unsuccessful angioplasty. Jpn Heart J. 1992;33:869-873. (Pubitemid 23092922)
23. Ino T, Akimoto K, Ohkubo M, Nishimoto K, Yabuta K, Takaya J, Yamaguchi H. Application of percutaneous transluminal coronary angioplasty to coronary arterial stenosis in Kawasaki disease. Circulation. 1996;93:1709-1715. (Pubitemid 26131348)
24. Akagi T. Interventions in Kawasaki disease. Pediatr Cardiol. 2005;26: 206-212. (Pubitemid 41491651)
25. Oesterle SN, Whitbourn R, Fitzgerald PJ, Yeung AC, Stertzer SH, Dake MD, Yock PG, Virmani R. The stent decade: 1987 to 1997: Stanford Stent Summit faculty. Am Heart J. 1998;136:578-99. (Pubitemid 28483499)
26. Tsuda E, Kitamura S; Cooperative Study Group of Japan. National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation. 2004;110(suppl):II-61-II-66. (Pubitemid 39263700)
27. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant. 2007;40:381-387. (Pubitemid 47202424)
28. Kishimoto S, Suda K, Iemura M. Progressive left coronary stenosis after rotablator ablation appreciated by Doppler echocardiography. Pediatr Cardiol. 2009;30:1190-1191.
29. Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, Kuroe K, Shimpo H, Nakano M, Komada Y. Elevated levels of highsensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation. 2005;111:38-43. (Pubitemid 40070841)
30. Cheung YF, O K, Woo CW, Armstrong S, Siow YL, Chow PC, Cheung EW. Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness. BMC Pediatr. 2008;8:20.
31. Noto N, Okada T, Karasawa K, Ayusawa M, Sumitomo N, Harada K, Mugishima H. Age-related acceleration of endothelial dysfunction and subclinical atherosclerosis in subjects with coronary artery lesions after Kawasaki disease. Pediatr Cardiol. 2009;30:262-268.
32. Tsuda E, Miyazaki S, Yamada O, Takamuro M, Takekawa T, Echigo S. Percutaneous transluminal coronary rotational atherectomy for localized stenosis caused by Kawasaki disease. Pediatr Cardiol. 2006;27:447-453. (Pubitemid 44222397)
33. Muta H, Ishii M. Percutaneous coronary intervention versus coronary artery bypass grafting for stenotic lesions after Kawasaki disease. J Pediatr. 2010;157:120-126.
34. Miyazaki A, Tsuda E, Miyazaki S, Kitamura S, Tomita H, Echigo S. Percutaneous transluminal coronary angioplasty for anastomotic stenosis after coronary arterial bypass grafting in Kawasaki disease. Cardiol Young. 2003;13:284-289. (Pubitemid 41630895)
35. Suda K, Mastumoto M, Miyanishi S. Intermittent heparin infusion in children with ischemic heart disease caused by Kawasaki disease. Int J Cardiol. 2009;133:417-419.
36. Kamiya T. How to evaluate the myocardial ischemic in Kawasaki disease. In: Kato H, ed. Kawasaki Disease. Amsterdam, Netherlands: Elsevier; 1995:447-450.
37. Miyagawa M, Mochizuki T, Murase K, Tanada S, Ikezoe J, Sekiya M, Hamamoto K, Matsumoto S, Niino M. Prognostic value of dipyridamole- thallium myocardial scintigraphy in patients with Kawasaki disease. Circulation. 1998;98:990-996. (Pubitemid 28446652)
38. Muta H, Ishii M, Iemura M, Matsuishi T. Health-related quality of life in adolescents and young adults with a history of Kawasaki disease. J Pediatr. 2010;156:439-443.